A recent study in mice showed that inhibition of PHD2 increases the HCC occurrence and stimulates the development of cholangiocarcinoma.16 However, little is known about the association between PHD2 and HCC in a clinical setting. This evidence concerns the gene EGLN1 and hepatocellular carcinoma.